Cell Lysis & Disruption Market is Likely To Touch USD 8.37 Billion by 2028: Grand View Research Inc.

 Cell Lysis & Disruption Market Growth & Trends

The global cell lysis & disruption market size is expected to reach USD 8.37 billion by 2028, registering a CAGR of 9.35% over the forecast period, according to a new report by Grand View Research, Inc. The anticipated revenue growth is attributed to accelerating the adoption of cell lysis and disruption methods during downstream processing to manufacture bio-therapeutics and other animal-based recombinant products. Technological developments in procedures involved in releasing cellular organelles have paved the way for the higher adoption of cell disruption methods.

As retrieval and purification of biopharmaceuticals involve cell disruption, a rise in demand for biopharma would lead to the subsequent growth of the market. In addition, advancements in the field of proteomics, metabolomics, and personalized medicine are expected to fuel progressive changes in this sector. However, the high costs of equipment coupled with the dearth of skilled professionals are expected to restrain revenue generation to a certain extent. The restraint can be addressed as the government organizations are releasing substantial funds to support development in the biotechnology sector.

Enzymatic lysis, owing to higher biological specificity, is likely to register the fastest CAGR over the forecast period. Manufacturers are embracing the trend of providing synthetic enzymes and pre-formulated kits, which can be used for the extraction and purification of proteins, DNA, and RNA. Sonication instruments in the products available are expected to witness lucrative growth due to higher adoption rates as a result of the reliability on these instruments. Factors attributing to this reliability include complete control allowed on parameters and negligible maintenance.

Among the physical methods, the high product yield obtained by sonication of the liquid sample is attributed to the larger revenue share of the ultrasonic homogenization method/technique. Asia Pacific will be the fastest-growing regional market from 2021 to 20285 due to lucrative opportunities offered by emerging nations, which has attracted investments from global firms in the region. Key companies are engaged in new product development and strategic alliances to maintain their market share.

Request a free sample copy or view report summary: Cell Lysis & Disruption Market Report

Cell Lysis & Disruption Market Report Highlights

• A rise in the development of biologics has subsequently led to high demand for better bioprocess solutions
• The advantages offered by reagent-based methods for isolation of biological products is attributive to the largest share of the segment in 2020
• The advantages include an unaltered biological activity of the sample of interest and ideal compatibility with the laboratory reagents
• Therefore, key players have developed different detergent-based solutions and buffers, to provide the best possible results for particular tissue types
• Mammalian cell culture systems have grabbed substantial attention among biopharmaceutical manufacturers, thus leading to higher demand for cell lysis protocols for the same
• Pharmaceutical & biotechnology companies accounted for the largest share as a result of the growing demand for biopharmaceutical products
• Substantial research in the development of nucleic-acid derived products is expected to drive progress in this application in the coming years

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cell-lysis-disruption-market

Cell Lysis & Disruption Market Segmentation

Grand View Research has segmented the global cell lysis & disruption market on the basis of technique, product, cell type, application, end use, and region:

Cell Lysis & Disruption Technique Outlook (Revenue, USD Million, 2018 - 2028)

• Reagent-based
  • Detergent
  • Enzymatic
• Physical Disruption
  • Mechanical Homogenization
  • Ultrasonic Homogenization
  • Pressure Homogenization
  • Temperature Treatments

Cell Lysis & Disruption Product Outlook (Revenue, USD Million, 2018 - 2028)

• Instruments
  • High-pressure Homogenizers
  • Sonicator
  • French Press
  • Microfluidizer
  • Bead Mill
  • Other Instruments
• Reagents & Consumables
  • Enzymes
  • Detergent Solutions
    • Ionic detergent
    • Nonionic detergent
    • Zwitterionic detergent
  • Kits & Reagents

Cell Lysis & Disruption Cell Type Outlook (Revenue, USD Million, 2018 - 2028)

• Mammalian cells
• Bacterial cells
• Yeast/Algae/Fungi
• Plant cells

Cell Lysis & Disruption Application Outlook (Revenue, USD Million, 2018 - 2028)

• Protein Isolation
• Downstream Processing
• Cell Organelle Isolation
• Nucleic Acid Isolation

Cell Lysis & Disruption End-use Outlook (Revenue, USD Million, 2018 - 2028)

• Academic & Research Institutes
• Hospitals & Diagnostic Labs
• Cell Banks
• Pharmaceutical & Biotechnology Companies

Cell Lysis & Disruption Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Cell Lysis & Disruption Market

• Merck KGaA
• Hoffmann-La Roche Ltd.
• Qiagen NV
• Becton Dickinson & Company (BD)
• Danaher Corp.
• Bio-Rad Laboratories, Inc.
• Miltenyi Biotec GmbH
• Claremont BioSolutions, LLC
• Microfluidics International Corp.
• Parr Instrument Company
• BioVision, Inc.
• Covaris, Inc.
• Qsonica LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.